Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone LAI Multiple-Dosing in Japanese Schizophrenia Patients
NCT00653406Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Nov 2002
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of risperidone in schizophrenia, sponsored by Janssen Pharmaceutical. Started Nov 2002; status: completed.
02
Drugs
risperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00653406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00653406.